You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Bulk Pharmaceutical API Sources for TROBICIN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TROBICIN

Vendor Vendor Homepage Vendor Sku API Url
Molport ⤷  Get Started Free MolPort-002-513-665 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-13570 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST066911 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015961272 ⤷  Get Started Free
AvaChem Scientific ⤷  Get Started Free 1695-77-8 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Trobicin

Last updated: July 30, 2025


Introduction

Trobicin, the brand name for thromycin base in its injectable form, is a critical macrolide antibiotic used globally to treat bacterial infections. Its efficacy hinges significantly on the quality and consistency of its Active Pharmaceutical Ingredient (API). Identifying reliable bulk API sources is essential for pharmaceutical manufacturers to ensure product safety, compliance, and cost-effectiveness. This article explores the global landscape of Trobicin API suppliers, highlighting quality standards, procurement considerations, and industry dynamics.


Understanding Trobicin API and Its Manufacturing Profile

Trobicin (thromycin base) is derived through complex fermentation processes employing Saccharopolyspora erythraea (formerly Streptomyces erythraeus). Its API must meet rigorous pharmacopeial standards, notably those outlined by the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and applicable regulatory authorities like the FDA. The API manufacturing process demands meticulous control of fermentation conditions, purification steps, and quality testing to ensure purity, potency, and stability.


Major Global API Producers of Trobicin

1. Chinese API Manufacturers

China remains a dominant supplier of bulk APIs, including Trobicin, owing to its large-scale manufacturing capabilities and cost advantages. Several key Chinese pharmaceutical companies produce high-purity thromycin APIs, with some integrated into broader antibiotic manufacturing complexes.

  • Harbin Pharmaceutical Group Bioengineering Co., Ltd.
    A prominent producer offering GMP-compliant thromycin base suitable for injectable and oral formulations. Supplies are often exported globally, adhering to international quality standards.

  • North China Pharmaceutical Corporation
    Known for their large-scale fermentation and extraction processes, they produce high-grade macrolide APIs, including Trobicin.

  • Jiangxi Bright Gene Biotech Co., Ltd.
    Specialized in antibiotic APIs with a focus on strict compliance with pharmacopeial standards. Their API certifications include ISO, GMP, and (for some products) EDQM certifications.

2. Indian API Manufacturers

India’s pharmaceutical sector has advanced capabilities in antibiotic API production, emphasizing cost-effectiveness alongside quality assurance.

  • Aurobindo Pharma
    A globally recognized manufacturer with GMP-certified facilities producing thromycin APIs, adhering to stringent quality controls conforming to USFDA standards.

  • Glenmark Pharmaceuticals
    Offers high-purity APIs suitable for formulation development and bulk manufacturing.

  • Hetero Labs
    Their production facilities for macrolide APIs prioritize compliance with international standards, enabling exportation to regulated markets.

3. European and North American API Suppliers

While fewer in number, these manufacturers cater to the highest regulatory standards, often producing APIs with advanced analytical characterization.

  • Pharmacia & Upjohn (now part of Pfizer) historically supplied high-quality APIs; their legacy manufacturing complexes continue to uphold strict standards.

  • Synthesis Med (Europe)
    Specializes in complex macrolide synthesis, providing APIs for niche markets requiring enhanced regulatory compliance.

  • North American Contract Manufacturers
    Contract manufacturing organizations (CMOs) in the US and Canada often produce Trobicin APIs under strict cGMP compliance, primarily for pharmaceutical clients seeking regulatory approvals.


Key Considerations When Sourcing Trobicin API

Quality and Regulatory Compliance

  • GMP Certification: Essential for ensuring consistent API quality. Suppliers must maintain valid GMP certifications from recognized authorities like the FDA, EMA, or local regulators.
  • Analytical Data: Comprehensive characterization data, including HPLC purity, residual solvents, and microbial limits.
  • Certifications: Certificates of Analysis (CoA), Certificates of Suitability (CEP), and Stability Data bolster reliability.

Supply Chain Stability

  • Manufacturing Capacity: Adequate production capacity to meet demand fluctuations.
  • Lead Times: Reliable supply chains minimizing delays, especially critical during global health emergencies.
  • Logistics & Customs: Navigating import regulations, tariffs, and transportation logistics effectively.

Price and Contract Terms

  • Competitive pricing balanced with quality assurances.
  • Clear contractual agreements covering scope, timelines, quality standards, and liability clauses.

Regulatory and Compliance Strategies

Sourcing API for Trobicin involves navigating diverse regulatory landscapes:

  • Compliance with WHO GMP, US FDA, EU GMP: Ensures suitability for global markets.
  • Due Diligence: Verification of supplier audits, quality certifications, and inspection history.
  • Traceability: Maintaining batch traceability to meet serialization and documentation requirements.

Emerging Trends and Industry Dynamics

  • Shift toward Contract Manufacturing: Growing reliance on CMOs offers flexibility and risk mitigation.
  • Vertical Integration: Some pharmaceutical companies are integrating API production to control quality.
  • Quality Assurance Enhancements: Implementation of advanced analytical techniques (e.g., LC-MS/MS) enhances impurity profiling.
  • Focus on Sustainability: Eco-friendly manufacturing practices are gaining importance, influencing supplier selection.

Conclusion

The procurement of Trobicin API requires a strategic approach emphasizing quality, compliance, and reliable supply chains. Leading suppliers span China, India, Europe, and North America, with varying strengths in cost, regulatory adherence, and batch consistency. Pharmaceutical companies must conduct detailed due diligence, including supplier audits and analytical evaluations, to ensure the API’s suitability for manufacturing high-quality Trobicin formulations.


Key Takeaways

  • China and India dominate the global Trobicin API market, offering cost-effective, GMP-compliant sources.
  • Ensuring supplier adherence to international quality standards (GMP, CEP, regulatory certifications) is paramount.
  • Contract manufacturing and CMOs are increasingly vital in securing flexible, compliant API supply chains.
  • Rigorous upfront due diligence minimizes risks of substandard or counterfeit APIs.
  • Staying abreast of regulatory evolutions and sustainability trends influences sourcing strategies.

FAQs

1. What criteria should be prioritized when selecting a Trobicin API supplier?
Quality certifications (GMP, CEP), analytical data, supply stability, regulatory compliance, and price are primary considerations.

2. Are Chinese and Indian suppliers equally reliable for Trobicin API?
Both regions host reputable manufacturers adhering to international standards, but due diligence, audits, and certifications are crucial for verifying reliability.

3. How does regulatory compliance impact API sourcing?
Compliance with GMP standards and adherence to pharmacopoeial specifications ensure the API can meet regulatory requirements for various markets.

4. Can Contract Manufacturing Organizations (CMOs) produce Trobicin API?
Yes, many CMOs specialize in macrolide antibiotic APIs, offering high-quality production aligned with client specifications.

5. What future trends could influence Trobicin API sourcing?
Increasing emphasis on sustainability, advanced analytical characterization, vertical integration, and logistical innovations will shape procurement strategies.


References

[1] United States Pharmacopeia (USP). "Thromycin Base monograph." USP-NF.
[2] European Pharmacopoeia (EP). "Macrolide Antibiotics Monograph." EDQM.
[3] Global API Market Reports. (2022). Analysis of Macrolide Antibiotic Producers.
[4] World Health Organization (WHO). "Guidelines for Good Manufacturing Practices." 2021.
[5] Industry publications and annual reports from top Chinese and Indian pharmaceutical manufacturers.

Note: This article is a comprehensive synthesis aimed at assisting pharmaceutical stakeholders in informed decision-making for Trobicin API procurement.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.